Neovasc Inc
-0.23 (-0.79%)


Draw Mode:

Volume 18,603
Bid Price 29.05
Ask Price 29.76
News -
Day High 29.3699


52 Week Range


Day Low 29.20
Company Name Stock Ticker Symbol Market Type
Neovasc Inc NVCN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.23 -0.79% 29.05 17:36:42
Open Price Low Price High Price Close Price Prev Close
29.20 29.20 29.3699 29.26 29.28
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
191 18,603 $ 29.28 $ 544,722 - 0.29 - 29.88
Last Trade Time Type Quantity Stock Price Currency
17:43:08 98 $ 29.06 USD

Neovasc Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 80.16M 2.76M 2.75M $ 2.35M $ - - 0.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - -

more financials information »

Neovasc News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No NVCN Message Board. Create One! See More Posts on NVCN Message Board See More Message Board Posts

Historical NVCN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week29.1029.64529.0429.3734,560-0.05-0.17%
1 Month28.3629.8828.2929.1936,2250.692.43%
3 Months15.1029.8812.9226.3864,15913.9592.38%
6 Months6.4829.886.1524.2133,72622.57348.3%
1 Year0.40829.880.2910.6242,84828.647,020.1%
3 Years1.8429.880.291.63908,09727.211,478.8%
5 Years12.1929.880.294.376,382,06216.86138.31%

Neovasc Description

Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Israel and Europe. The company earns revenue from one source, the Reducer.